Enjoy complimentary customisation on priority with our Enterprise License!
According to the immunoglobulin products industry insights, Technavio’s market research analyst has estimated that this market will grow at a CAGR of almost 7% during the estimated period. The recent approval of immunoglobulins to treat neuroimmunological disorders is a noteworthy factor that will impel the prospects for the growth of immunoglobulin products market size until the end of the forecast period. Recently, immunoglobulin products were approved for the treatment of neuroimmunological disorders like multifocal motor neuropathy, Alzheimer's disease, and Guillain-Barré syndrome. Due to its widespread applicability, immunoglobulin products that are utilized for the treatment of neuroimmunological disorders are anticipated to contribute the largest proportion of revenue to the global immunoglobulin products market in the next few years. Immunoglobulin products used for the treatment of primary immunodeficiency disease (PID) and neuroimmunological disorders account for around 90% of the total market revenue.
In terms of geography, the Americas will be the largest market for immunoglobulin products during the forecast period and will generate revenues of nearly USD 9 billion by the end of 2020. The high incidence of PID and other autoimmune diseases in the US and Canada is a major factor that will spur the prospects for market growth until 2020. In addition, factors such as the affordability of therapies due to the presence of well-structured reimbursement plans will also augment market growth in the Americas during the next four years.
In 2015, the global immunoglobulin products market was dominated by the IgG segment, which accounted for approximately 77% of the total market share. IgGs are the smallest antibodies and account for nearly 75%-80% of all the antibodies in the body. The ability of these antibodies to fight against bacterial and viral infections will lead to its increased adoption during the forecast period.
The IVIG products segment accounted for around 60% of the total market share during 2015 and is anticipated to retain its hold over the market throughout the forecast period. Increasing global incidence of CIDP, hypogammaglobulinemia, and immunodeficiency diseases is a critical factor that will spur the prospects for growth in this market segment. In addition, the recent increase in prescriptions of IVIG to treat off-label indications such as Guillain–Barré syndrome, specific antibody deficiency, and inflammatory myopathies will also aid in the growth of this market segment over the next few years.
The global immunoglobulin products market is growing at a significant pace because of the augmented demand for immunoglobulins, especially IVIG, to treat rare diseases. Though the leading players dominate this market, emerging players like Biotest and Bharat Biotech are likely to pose a threat to the established vendors in the market.
Top vendors in the market are
Other prominent vendors in this market are Abeona Therapeutics, Admabiologics, Anthera, Beijing Tiantan Biological Products (China), Bharat Serums and Vaccines (India), Bio Products Laboratory, China Biologic Products (China), Emergent Biosolutions, Gliknik, Greencross, Hansamedical, Hualan Biological Engineering (China), Immunomedics, Innate Pharma, Integrated Biotherapeutics, Janssen Pharmaceuticals, Kamada, LFB Group (France), Mitsubishi Tanabe Pharma, Momenta Pharma, Patrys, Shanghai RAAS Blood Products (China), Sichuan Yuanda Shuyang Pharmaceutical (China), and Sorrento Therapeutics.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Plasma products: An overview
PART 06: Regulation of plasma products
PART 07: Pipeline portfolio
PART 08: Market landscape
PART 09: Market segmentation by type of immunoglobulins
PART 10: Market segmentation by application
PART 11: Market segmentation by ROA
PART 12: Market segmentation by volume
PART 13: Geographical segmentation
PART 14: Market drivers
PART 15: Impact of drivers
PART 16: Market challenges
PART 17: Impact of drivers and challenges
PART 18: Market trends
PART 19: Vendor landscape
PART 20: Appendix
PART 21: Explore Technavio
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.